With more than 180 COVID-19 vaccines currently in development1 — 53 of them undergoing clinical trials in humans2 — manufacturers are racing to be the first to reach the market. Pfizer, in a joint venture with Germany-based BioNTech, may have just taken the lead, with an announcement that their mRNA-based vaccine candidate, BNT162b2, was “more… Read More »
Dive Brief: Demand for temporary healthcare staff is on the rise again as systems across the country face a record number of COVID-19 cases. Staffing firm Aya Healthcare reported a 57% increase in demand for travel nurses over the past 30 days and posted 24,115 open positions as of Monday. Open “crisis nursing” positions increased 291%… Read More »
By Adam Vaughan A biologist takes a coronavirus DNA sample from the freezer at the Technological Vaccine Center of the Federal University of Minas Gerais, in Belo Horizonte, Brazil.Pedro Vilela/Getty Images We have a covid-19 vaccine that works. But can we keep it cold enough to get it to enough people? Among Pfizer and BioNTech’s… Read More »
Medical researchers are raising significant doubts about whether an agent of the human immune system causes some coronavirus patients to end up in the hospital with injured lungs and other organs, struggling to breathe. What remains is a continuing mystery about what causes certain people to die from Covid-19, and how best to prevent that.… Read More »
The boss of NHS England, Sir Simon Stevens, told a Downing Street press conference on Thursday that flu and other winter conditions usually brought in 3,000 additional patients to hospitals, but there were already more than 10,000 coronavirus patients in England before winter pressures have even arrived. BBC News – Health